BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32369814)

  • 1. Dose Issues in Cancer Chemotherapy.
    Rizvi SAA; Shahzad Y; Saleh AM; Muhammad N
    Oncology; 2020; 98(8):520-527. PubMed ID: 32369814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate is lethal to rats. Why give it to children?
    Cole PD; Kamen BA
    Pediatr Hematol Oncol; 2000 Dec; 17(8):609-13. PubMed ID: 11127392
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature.
    Bielack SS; Beron G; Winkler K
    Cancer; 1997 Aug; 80(3):516-8. PubMed ID: 9241087
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma.
    Kawai A; Sugihara S; Kunisada T; Hamada M; Inoue H
    Arch Orthop Trauma Surg; 1996; 115(2):68-70. PubMed ID: 9063854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinic.
    Evans WE; Pui CH; Relling MV
    Adv Exp Med Biol; 1999; 457():537-41. PubMed ID: 10500831
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring of methotrexate after its administration in high-dose protocols].
    Le Guellec C; Blasco H; Benz I; Hulin A;
    Therapie; 2010; 65(3):163-9. PubMed ID: 20699066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use?
    Mantadakis E; Cole PD; Kamen BA
    Pharmacotherapy; 2005 May; 25(5):748-55. PubMed ID: 15899736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.
    Freeman AI; Boyett JM; Glicksman AS; Brecher ML; Leventhal BG; Sinks LF; Holland JF
    Med Pediatr Oncol; 1997 Feb; 28(2):98-107. PubMed ID: 8986145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of oral antimetabolite "maintenance" therapy in childhood lymphoblastic leukemia.
    Lilleyman JS
    Pediatr Hematol Oncol; 1996; 13(5):vii-x. PubMed ID: 10897808
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
    Estlin EJ; Lowis SP; Hall AG
    Br J Haematol; 2000 Jul; 110(1):29-40. PubMed ID: 10930977
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate eluted from bone cement: effect on giant cell tumor of bone in vitro.
    Kirchen ME; Menendez LR; Lee JH; Marshall GJ
    Clin Orthop Relat Res; 1996 Jul; (328):294-303. PubMed ID: 8653971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology.
    Starý J; Gajdos P; Hrstková H; Blazek B; Slavík Z; Mihál V; Zahálka F; Jabali Y; Vávra V; Kopecná L; Mydlil J; Trka J
    Med Pediatr Oncol; 2002 Aug; 39(2):125-7. PubMed ID: 12116061
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetics of high-dose methotrexate-induced oral mucositis: current perspectives.
    Heil SG
    Pharmacogenomics; 2019 Jun; 20(9):621-623. PubMed ID: 31250729
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate nephrotoxicity: Novel treatment, new approach.
    Iqbal S; Armaghani A; Aiyer R; Kazory A
    J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
    Caglar K; Ozyönüm H; Akalin M; Balci S
    Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate in childhood all.
    Moe PJ; Holen A
    Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
    Mir O; Ropert S; Goldwasser F
    Lancet Oncol; 2008 Dec; 9(12):1198. PubMed ID: 19038767
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
    Tsao TF; Chao YH
    Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.